Recursion Pharmaceuticals, Inc. RXRX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $665.18M-11.8% | $753.92M+13.0% | $667.15M+25.0% | $533.85M+4.8% | $509.16M-15.6% | ||
| $709.56M-12.7% | $812.85M+13.8% | $714.11M+21.6% | $587.16M+0.5% | $584.15M-18.2% | ||
| $95.81M-7.8% | $103.93M-7.0% | $111.71M-6.9% | $120.04M-5.4% | $126.83M-10.1% | ||
| $160.17M-1.2% | $162.16M+0.1% | $162.04M-1.4% | $164.27M+3.9% | $158.11M+6.2% | ||
| $294.07M-5.1% | $309.9M-3.9% | $322.34M-5.6% | $341.32M+1.6% | $335.79M0.0% | ||
| $1.34B-9.1% | $1.47B+5.3% | $1.4B+7.5% | $1.3B-0.2% | $1.31B-9.9% | ||
| $71.72M-6.2% | $76.45M-4.4% | $79.95M+17.1% | $68.27M+29.5% | $52.72M+61.0% | ||
| $32.79M-12.8% | $37.61M-20.6% | $47.36M+19.3% | $39.69M+0.1% | $39.65M-35.8% | ||
| $9.27M+1.9% | $9.09M+1.9% | $8.92M+1.9% | $8.75M+1.9% | $8.59M— | ||
| $129.7M-12.2% | $147.71M-4.8% | $155.1M-5.4% | $164.03M+15.5% | $141.98M-24.3% | ||
| $7.18M-24.9% | $9.56M-19.6% | $11.9M-16.2% | $14.2M-13.7% | $16.45M-13.5% | ||
| $314.75M-8.3% | $343.27M-2.6% | $352.58M-8.0% | $383.21M+3.2% | $371.29M-10.3% | ||
| 2B0.0% | 2B0.0% | 2B0.0% | 2B0.0% | 2B+49,999,900% | ||
| -$2.19B-5.7% | -$2.08B-5.5% | -$1.97B-9.0% | -$1.81B-10.5% | -$1.63B-14.1% | ||
| $1.02B-9.4% | $1.13B+8.0% | $1.05B+13.9% | $919.15M-1.6% | $933.95M-9.7% | ||
| $1.34B-9.1% | $1.47B+5.3% | $1.4B+7.5% | $1.3B-0.2% | $1.31B-9.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Recursion Pharmaceuticals, Inc.'s total assets?
- Recursion Pharmaceuticals, Inc. (RXRX) holds $1.3B in total assets, up 2.6% year over year.
- How much debt does Recursion Pharmaceuticals, Inc. have?
- Recursion Pharmaceuticals, Inc. carries $88.6M in total debt against $1.0B of shareholders' equity, a debt-to-equity ratio of 0.09.
- How much cash does Recursion Pharmaceuticals, Inc. have?
- Recursion Pharmaceuticals, Inc. holds $665.2M in cash and equivalents.
- Can Recursion Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 5.47 — current assets exceed current liabilities.
- Where does Recursion Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Recursion Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
